Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 4:2019:2075614.
doi: 10.1155/2019/2075614. eCollection 2019.

Medicinal Plants in the Prevention and Treatment of Colon Cancer

Affiliations
Review

Medicinal Plants in the Prevention and Treatment of Colon Cancer

Paola Aiello et al. Oxid Med Cell Longev. .

Abstract

The standard treatment for cancer is generally based on using cytotoxic drugs, radiotherapy, chemotherapy, and surgery. However, the use of traditional treatments has received attention in recent years. The aim of the present work was to provide an overview of medicinal plants effective on colon cancer with special emphasis on bioactive components and underlying mechanisms of action. Various literature databases, including Web of Science, PubMed, and Scopus, were used and English language articles were considered. Based on literature search, 172 experimental studies and 71 clinical cases on 190 plants were included. The results indicate that grape, soybean, green tea, garlic, olive, and pomegranate are the most effective plants against colon cancer. In these studies, fruits, seeds, leaves, and plant roots were used for in vitro and in vivo models. Various anticolon cancer mechanisms of these medicinal plants include induction of superoxide dismutase, reduction of DNA oxidation, induction of apoptosis by inducing a cell cycle arrest in S phase, reducing the expression of PI3K, P-Akt protein, and MMP as well; reduction of antiapoptotic Bcl-2 and Bcl-xL proteins, and decrease of proliferating cell nuclear antigen (PCNA), cyclin A, cyclin D1, cyclin B1 and cyclin E. Plant compounds also increase both the expression of the cell cycle inhibitors p53, p21, and p27, and the BAD, Bax, caspase 3, caspase 7, caspase 8, and caspase 9 proteins levels. In fact, purification of herbal compounds and demonstration of their efficacy in appropriate in vivo models, as well as clinical studies, may lead to alternative and effective ways of controlling and treating colon cancer.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interest regarding the publication of this paper.

Figures

Figure 1
Figure 1
Cell damage and cancer trigger p53 activation. The p53 protein activates the apoptotic protein Bax. Bax inhibits the antiapoptotic protein Bcl-2. During apoptosis, cytochrome c is released from mitochondria. To activate the Apaf-1 protein, the interaction between these proteins and cytochrome C is necessary. Pro-caspase 9 attaches to Apaf-1 and activates caspase 9. Caspase 9 activates caspases 3 and 7 and apoptosis occurs.

References

    1. Watson A. J. M., Collins P. D. Colon cancer: a civilization disorder. Digestive Diseases. 2011;29(2):222–228. doi: 10.1159/000323926. - DOI - PubMed
    1. Huxley R. R., Ansary-Moghaddam A., Clifton P., Czernichow S., Parr C. L., Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. International Journal of Cancer. 2009;125(1):171–180. doi: 10.1002/ijc.24343. - DOI - PubMed
    1. Schultz D. J., Wickramasinghe N. S., Ivanova M. M., et al. Anacardic acid inhibits estrogen receptor α–DNA binding and reduces target gene transcription and breast cancer cell proliferation. Molecular Cancer Therapeutics. 2010;9(3):594–605. doi: 10.1158/1535-7163.MCT-09-0978. - DOI - PMC - PubMed
    1. Johns L. E., Houlston R. S. A systematic review and meta-analysis of familial colorectal cancer risk. The American Journal of Gastroenterology. 2001;96(10):2992–3003. doi: 10.1111/j.1572-0241.2001.04677.x. - DOI - PubMed
    1. Meyerhardt J. A., Catalano P. J., Haller D. G., et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. Journal of Clinical Oncology. 2003;21(3):433–440. doi: 10.1200/JCO.2003.07.125. - DOI - PubMed

Substances